Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Over the last 12 months, insiders at Celldex Therapeutics, Inc. have bought $0 and sold $12.09M worth of Celldex Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Celldex Therapeutics, Inc. have bought $76,744 and sold $5.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 430 shares for transaction amount of $19,900 was made by Jimenez Freddy A. (SVP & General Counsel) on 2021‑08‑11.
2024-06-14 | Sale | Martin Samuel Bates | SVP AND CFO | 17,172 0.0259% | $35.42 | $608,315 | +2.34% | |
2024-06-14 | Sale | Crowley Elizabeth | SR. VP & CPDO | 30,000 0.0446% | $34.87 | $1.05M | +2.34% | |
2024-06-07 | Sale | Crowley Elizabeth | SR. VP & CPDO | 15,000 0.0226% | $35.06 | $525,873 | +0.82% | |
2024-06-07 | Sale | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 45,000 0.0682% | $35.26 | $1.59M | +0.82% | |
2024-06-03 | Sale | Jimenez Freddy A. | SVP & GENERAL COUNSEL | 8,006 0.0122% | $33.60 | $269,002 | +5.41% | |
2024-06-03 | Sale | Wright Richard M. | SR. VP & CCO | 46,844 0.0716% | $33.72 | $1.58M | +5.41% | |
2024-06-03 | Sale | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 58,369 0.089% | $33.65 | $1.96M | +5.41% | |
2024-05-30 | Sale | Martin Samuel Bates | SVP AND CFO | 35,000 0.0538% | $34.05 | $1.19M | +4.43% | |
2024-05-30 | Sale | Crowley Elizabeth | SR. VP & CPDO | 38,597 0.0586% | $33.64 | $1.3M | +4.43% | |
2024-05-30 | Sale | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 38,719 0.0595% | $34.07 | $1.32M | +4.43% | |
2024-05-30 | Sale | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 20,853 0.0317% | $33.73 | $703,334 | +4.43% | |
2022-12-07 | Sale | KELER TIBOR | EXECUTIVE VP & CSO | 16,860 0.0356% | $36.93 | $622,611 | -7.99% | |
2022-08-17 | Sale | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 19,000 0.0411% | $37.30 | $708,715 | -4.68% | |
2022-08-17 | Sale | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 1,355 0.0029% | $36.38 | $49,289 | -4.68% | |
2022-08-15 | Sale | Marucci Anthony S | PRESIDENT & CEO | 120,000 0.2564% | $37.66 | $4.52M | -6.53% | |
2022-08-15 | Sale | Wright Richard M. | SR. VP & CCO | 15,328 0.0328% | $37.71 | $578,048 | -6.53% | |
2022-08-11 | Sale | Martin Samuel Bates | SVP AND CFO | 14,261 0.0324% | $36.76 | $524,304 | +1.90% | |
2021-12-23 | Sale | Martin Samuel Bates | SVP and CFO | 9,500 0.0203% | $42.00 | $399,000 | -25.17% | |
2021-12-08 | Sale | Heath-Chiozzi Margo | SVP of Regulatory Affairs | 600 0.0013% | $40.00 | $24,000 | -20.89% | |
2021-12-08 | Sale | Crowley Elizabeth | Sr. VP &CPDO | 4,000 0.0086% | $40.00 | $160,000 | -20.89% |
Martin Samuel Bates | SVP AND CFO | 28125 0.0506% | $36.11 | 1 | 6 | +500.67% |
Heath-Chiozzi Margo | SVP of Regulatory Affairs | 13383 0.0206% | $36.11 | 1 | 4 | +500.67% |
Crowley Elizabeth | Sr. VP &CPDO | 9074 0.0086% | $36.11 | 0 | 5 | |
Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 2115 0.0039% | $36.11 | 1 | 3 | +105.94% |
Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 1860 0.0023% | $36.11 | 1 | 4 | +275.1% |
Jimenez Freddy A. | SVP & General Counsel | 25924 0.0008% | $36.11 | 1 | 1 | <0.0001% |
Wright Richard M. | SR. VP & CCO | 20833 0.0004% | $36.11 | 0 | 3 | |
MEDAREX INC | 10 percent owner | 2960848 5.414% | $36.11 | 0 | 2 | |
RYAN UNA S | President & CEO | 898713 1.6433% | $36.11 | 2 | 0 | |
SEARS PETER A | director | 72739 0.133% | $36.11 | 1 | 0 | |
ELLBERGER LARRY | director | 53500 0.0978% | $36.11 | 5 | 1 | +3.43% |
PAREKH RAJESH R | director | 40000 0.0731% | $36.11 | 1 | 3 | <0.0001% |
WARD J BARRIE | director | 35774 0.0654% | $36.11 | 0 | 1 | |
CATLIN AVERY W | Sr. VP & CFO | 35109 0.0642% | $36.11 | 5 | 3 | +20.69% |
Marucci Anthony S | PRESIDENT & CEO | 27692 0.0506% | $36.11 | 5 | 1 | +138.14% |
PENNER HARRY JR | director | 13416 0.0245% | $36.11 | 1 | 1 | +13.16% |
LIPTON KAREN SHOOS | director | 13333 0.0244% | $36.11 | 1 | 1 | +3.2% |
MARINO JAMES J | director | 12704 0.0232% | $36.11 | 2 | 0 | +231.19% |
KELER TIBOR | EXECUTIVE VP & CSO | 7357 0.0135% | $36.11 | 5 | 1 | +101.05% |
KYLE FREDERICK W | director | 7000 0.0128% | $36.11 | 0 | 2 | |
SCHALLER CHARLES R | director | 5000 0.0091% | $36.11 | 4 | 0 | +1.11% |
SHANNON TIMOTHY M | director | 3200 0.0059% | $36.11 | 1 | 0 | +11.03% |
Davis Thomas Andrew | Sr. VP & CMO | 1489 0.0027% | $36.11 | 1 | 0 | +3.2% |
Fidelity Investments | $408.2M | 14.76 | 9.73M | +37.95% | +$112.3M | 0.03 | |
Wellington Management Company | $320.96M | 11.6 | 7.65M | +18.08% | +$49.14M | 0.05 | |
BlackRock | $189.37M | 6.85 | 4.51M | +22.75% | +$35.1M | <0.01 | |
The Vanguard Group | $153.21M | 5.54 | 3.65M | +19.84% | +$25.36M | <0.01 | |
Eventide Asset Management | $130.91M | 4.73 | 3.12M | -14.07% | -$21.44M | 2.06 | |
T. Rowe Price | $129.57M | 4.68 | 3.09M | +631.06% | +$111.85M | 0.02 | |
Polar Capital | $128.41M | 4.64 | 3.06M | -2.44% | -$3.21M | 0.71 | |
State Street | $125.06M | 4.52 | 2.98M | +25.34% | +$25.28M | 0.01 | |
Kynam Capital Management Lp | $121.71M | 4.4 | 2.9M | -3.52% | -$4.44M | 1.54 | |
Bellevue Group | $117.37M | 4.24 | 2.8M | +15.74% | +$15.96M | 1.79 | |
Geode Capital Management | $59.37M | 2.15 | 1.41M | +26.51% | +$12.44M | 0.01 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $57.59M | 2.08 | 1.37M | +41.51% | +$16.89M | 1.47 | |
Point72 Asset Management | $53.88M | 1.95 | 1.28M | -53.42% | -$61.79M | 0.1 | |
Marshall Wace | $37.72M | 1.36 | 898,800 | -29.79% | -$16M | 0.05 | |
Redmile Group | $37.62M | 1.36 | 896,454 | -9.8% | -$4.09M | 1.39 | |
Commodore Capital, LP | $36.37M | 1.32 | 866,468 | +23.43% | +$6.9M | 2.56 | |
Sofinnova | $33.65M | 1.22 | 801,777 | -5% | -$1.77M | 0.07 | |
Woodline Partners LP | $31.52M | 1.14 | 751,060 | +93.75% | +$15.25M | 0.3 | |
Eversept Partners LP | $29.85M | 1.08 | 711,115 | -5.7% | -$1.8M | 2.25 | |
JENNISON ASSOCIATES LLC | $28.88M | 1.04 | 688,080 | +3,327.03% | +$28.04M | 0.02 | |
Logos Global Management Lp | $27.28M | 0.99 | 650,000 | New | +$27.28M | 2.93 | |
Ecor1 Capital Llc | $27.28M | 0.99 | 650,000 | New | +$27.28M | 0.69 | |
D. E. Shaw & Co. | $24.06M | 0.87 | 573,171 | +2,313.76% | +$23.06M | 0.03 | |
Goldman Sachs | $23.7M | 0.86 | 564,803 | +29.02% | +$5.33M | <0.01 | |
Northern Trust | $23.25M | 0.84 | 553,861 | +24.52% | +$4.58M | <0.01 | |
Affinity Asset Advisors | $21.4M | 0.77 | 510,000 | +27.5% | +$4.62M | 3.8 | |
Charles Schwab | $20.95M | 0.76 | 499,221 | +21.94% | +$3.77M | 0.01 | |
5Am Venture Management Llc | $20.87M | 0.75 | 497,270 | 0% | +$0 | 1.41 | |
Morgan Stanley | $15.79M | 0.57 | 376,121 | -42.87% | -$11.85M | <0.01 | |
Nuveen | $15.49M | 0.56 | 369,083 | +204.54% | +$10.4M | 0.01 | |
Candriam S C A | $13.33M | 0.48 | 317,509 | 0% | +$0 | 0.09 | |
Renaissance Technologies | $13.11M | 0.47 | 312,470 | New | +$13.11M | 0.02 | |
Silverarc Capital Management Llc | $12.56M | 0.45 | 299,316 | +21.07% | +$2.19M | 3.7 | |
Sphera Fund | $11.63M | 0.42 | 276,996 | -12.24% | -$1.62M | 1.92 | |
Bank of America | $11.4M | 0.41 | 271,611 | +24.7% | +$2.26M | <0.01 | |
UBS | $10.76M | 0.39 | 256,348 | +62.15% | +$4.12M | <0.01 | |
Artal Group S A | $10.62M | 0.38 | 253,000 | New | +$10.62M | 0.06 | |
Laurion Capital Management LP | $10.44M | 0.38 | 248,818 | +79.61% | +$4.63M | 0.29 | |
Tsp Capital Management Group Llc | $10.46M | 0.38 | 249,220 | -0.91% | -$95,481.77 | 3.46 | |
Baker Bros Advisors LP | $10.39M | 0.38 | 247,644 | 0% | +$0 | 0.13 | |
Td Asset Management Inc | $9.46M | 0.34 | 225,478 | +330.94% | +$7.27M | 0.01 | |
Natixis | $8.98M | 0.33 | 213,900 | New | +$8.98M | 0.05 | |
Invesco | $9M | 0.33 | 214,348 | -16.78% | -$1.81M | <0.01 | |
Emerald Advisers, Inc. | $8.9M | 0.32 | 212,035 | New | +$8.9M | 0.36 | |
Millennium Management LLC | $8.74M | 0.32 | 208,251 | +1,793.71% | +$8.28M | 0.01 | |
Qube Research & Technologies | $8.65M | 0.31 | 206,164 | +358.47% | +$6.77M | 0.01 | |
BNY Mellon | $8.43M | 0.31 | 200,838 | +18.74% | +$1.33M | <0.01 | |
LMR PARTNERS LLP | $8.39M | 0.3 | 200,000 | New | +$8.39M | 0.21 | |
Rafferty Asset Management Llc | $8.03M | 0.29 | 191,415 | +29.33% | +$1.82M | 0.02 | |
American Century Investments | $7.64M | 0.28 | 182,072 | +13.05% | +$882,251.85 | 0.01 |